What to eat on Ozempic, Wegovy, Mounjaro & Zepbound

GLP-1 receptor agonists (semaglutide and tirzepatide) suppress appetite, slow gastric emptying, and put most users in a sustained caloric deficit. The food choices that work on these medications are different from a generic "diet", protein-first, carb-aware, and friendly to a GI tract that's running slower than usual.

How GLP-1 medications change what you should eat

Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) both activate the GLP-1 receptor, and tirzepatide additionally activates GIP. The clinical effects relevant to nutrition:

• Slower gastric emptying. Food sits in the stomach longer, so large or very-fatty meals feel uncomfortable.
• Suppressed appetite. You feel full faster and stay full longer.
• Reduced "food noise." Many users describe a quieter relationship with cravings.
• Improved insulin sensitivity. Glucose response to meals is dampened.

The combination produces consistent weight loss in most users, but at a cost: it's easy to under-eat, especially under-eat protein, and lose meaningful muscle mass alongside fat. Published data from the SURMOUNT-1 (tirzepatide) and STEP (semaglutide) trials show that without intentional protein intake and resistance training, lean mass loss can account for 25–40% of total weight lost.

Protein: the most important macronutrient on GLP-1s

If you only do one thing on a GLP-1, hit your protein target. The clinical consensus for adults losing weight on these medications:

1.2 to 1.6 grams of protein per kilogram of bodyweight per day, spread across three meals.

Generalized recommendation, coordinate with your dietitian

For a 180 lb (82 kg) adult, that's 100–130g of protein per day, or roughly 35–45g per meal. That's a real amount: a 6 oz chicken breast is ~40g, three eggs are ~18g, a single-scoop whey shake is ~25g.

Why so much? Two reasons:

1. Protein has a satiety effect that doesn't depend on appetite. When the GLP-1 is doing the appetite work, you can still get the muscle-preservation benefit of protein because you don't need to feel hungry to eat it.
2. Protein has a high thermic effect. Roughly 25–30% of protein calories are burned in digestion, vs. 5–10% for carbs and 0–3% for fat.

How many carbs on Ozempic or Wegovy?

There is no required carbohydrate target on GLP-1 medications. People with normal A1C and good glucose tolerance can eat a typical carbohydrate distribution (~45% of calories). People with prediabetes or Type 2 diabetes often do better with moderate-carb intake (30–40% of calories), and with carbs that are slow rather than fast.

Slow carbs that pair well with GLP-1 medications:

• Steel-cut oats, quinoa, farro, barley, wild rice
• Beans and lentils (also a protein source)
• Sweet potato
• Berries, apple, pear
• Whole-grain sourdough

What to be cautious with:

• Sugary drinks. The GI tract on a GLP-1 doesn't love a sugar bolus.
• White bread, white rice, white pasta in large portions.
• Pastries and ultra-processed snacks, high carbs and high fat are double-trouble for nausea.

Fat, friend at the right amount, enemy at the wrong

Healthy fats (olive oil, avocado, nuts, salmon, eggs) are part of a balanced GLP-1 diet. Very-high-fat meals are the most common cause of GI side effects: greasy fast food, fried entrees, large portions of cheese, heavy cream sauces. The mechanism is straightforward, GLP-1s slow gastric emptying, fat slows it further, and the combination produces nausea or reflux.

Practical rule: keep added fat to about 1 tablespoon per meal and allow naturally occurring fat from protein sources. Reach for grilled, baked, or air-fried over deep-fried.

Hydration and electrolytes

Reduced food intake means reduced water intake from food. Many GLP-1 users report dehydration, headaches, and constipation in the first weeks. The fix:

• Aim for 80–100 oz of water daily.
• Salt your food. Sodium intake drops dramatically with reduced eating.
• Add a magnesium supplement (200–400mg) if constipation persists; coordinate with your prescriber.

Foods that worsen GLP-1 side effects

Patient-reported triggers for nausea, reflux, bloating, and "sulfur burps" cluster around a few categories:

• Deep-fried foods (fries, fried chicken, donuts)
• Very rich, creamy dishes (Alfredo, heavy curries, cream-based soups in large portions)
• Carbonated drinks
• Alcohol, particularly beer and sweet cocktails
• Sugary drinks and concentrated sweets
• Eating past the "first sign of fullness", the cue is real, listen to it

Meal templates that actually work

Breakfast (35–40g protein)

• 2 eggs + 1/2 cup cottage cheese + berries + black coffee
• Greek yogurt (1 cup) + 1 scoop whey + tablespoon nut butter
• 3-egg veggie omelet + 1/2 cup oats with cinnamon

Lunch (35–45g protein)

• 5 oz grilled chicken + big salad + 1/2 cup quinoa + olive oil dressing
• Tuna pouch + sourdough toast + cucumber + apple
• Lentil soup (1 cup) + grilled chicken thigh + side salad

Dinner (35–45g protein)

• 4 oz salmon + roasted broccoli + 1/2 sweet potato
• 5 oz lean ground beef + sautéed peppers + corn tortillas (2 small)
• Tofu stir-fry + brown rice (1/2 cup cooked)

Avoiding muscle loss

The goal isn't just "lose weight", it's lose fat while keeping muscle. Two interventions matter, in order:

1. Resistance training, 2–3 sessions per week. Bodyweight, dumbbells, or machines, anything that loads muscle.
2. Hit your protein target every day. Especially on days when you have less appetite. A whey shake counts as a meal.

Tracking what you eat without a food diary

Old-school food logging is a chore, and chores die first when you're tired. The pattern that works for most GLP-1 users:

• Track protein daily. That single number drives 80% of the muscle-preservation benefit.
• Take a photo of each meal, for memory, accountability, and (with a tool like CarbZen) automatic macro estimates.
• Weigh weekly, not daily. GLP-1 weight loss is rarely linear.

References

• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM 2021;384:989–1002.
• Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). NEJM 2022;387:205–216.
• Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Adv Nutr 2017;8(3):511–519.